Secondary neutrons in clinical proton radiotherapy: A charged issue

Radiotherapy and Oncology

Volumn 86, Issue 2, 2008, Pages 165-170

  Brenner, David J ^a   Hall, Eric J ^a  

^a Department of Medicine   (United States)

Author keywords

Passive scattering; Proton radiotherapy; Second cancers; Secondary neutrons

Indexed keywords

CANCER MORTALITY; CANCER RADIOTHERAPY; CANCER RISK; CARCINOGENESIS; COMPARATIVE STUDY; DOSE CALCULATION; HUMAN; LUNG TUMOR; MEASUREMENT; NEUTRON; NEUTRON DOSIMETRY; PRIORITY JOURNAL; PROTON RADIATION; PROTON THERAPY; REVIEW;

DOSE-RESPONSE RELATIONSHIP, RADIATION; HUMANS; NEOPLASMS; NEOPLASMS, RADIATION-INDUCED; NEUTRONS; PROTONS; RADIATION ONCOLOGY; RADIOTHERAPY, HIGH-ENERGY; SCATTERING, RADIATION;

EID: 39149114100     PISSN: 01678140     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.radonc.2007.12.003     Document Type: Review

References (64)

1. Chang J.Y., Zhang X., Wang X., et al. Significant reduction of normal tissue dose by proton radiotherapy compared with three-dimensional conformal or intensity-modulated radiation therapy in Stage I or Stage III non-small-cell lung cancer. Int J Radiat Oncol Biol Phys 65 (2006) 1087-1096
2. Miralbell R., Lomax A., Cella L., and Schneider U. Potential reduction of the incidence of radiation-induced second cancers by using proton beams in the treatment of pediatric tumors. Int J Radiat Oncol Biol Phys 54 (2002) 824-829
3. Hall E.J. Intensity-modulated radiation therapy, protons, and the risk of second cancers. Int J Radiat Oncol Biol Phys 65 (2006) 1-7
4. Gottschalk B. Neutron dose in scattered and scanned proton beams: in regard to Hall EJ (Int J Radiat Oncol Biol Phys 2006;65:1-7). Int J Radiat Oncol Biol Phys 2006;66:1594; author reply 1595.
5. Macklis R. In regard to Hall: intensity-modulated radiation therapy, protons, and the risk of second cancers (Int J Radiat Oncol Biol Phys 2006;65:1-7). Int J Radiat Oncol Biol Phys 2006;66:1593-4; author reply 1595.
6. Paganetti H, Bortfeld T, Delaney TF. Neutron dose in proton radiation therapy: in regard to Hall EJ (Int J Radiat Oncol Biol Phys 2006;65:1-7). Int J Radiat Oncol Biol Phys 2006;66:1594-5; author reply 1595.
7. Agosteo S., Birattari C., Caravaggio M., Silari M., and Tosi G. Secondary neutron and photon dose in proton therapy. Radiother Oncol 48 (1998) 293-305
8. Binns P.J., and Hough J.H. Secondary dose exposures during 200 MeV proton therapy. Radiat Prot Dosimetry 70 (1997) 441-444
9. Fontenot J.D., Newhauser W.D., and Titt U. Design tools for proton therapy nozzles based on the double-scattering foil technique. Radiat Prot Dosimetry 116 (2005) 211-215
10. Jiang H., Wang B., Xu X.G., Suit H.D., and Paganetti H. Simulation of organ-specific patient effective dose due to secondary neutrons in proton radiation treatment. Phys Med Biol 50 (2005) 4337-4353
11. Mesoloras G., Sandison G.A., Stewart R.D., Farr J.B., and Hsi W.C. Neutron scattered dose equivalent to a fetus from proton radiotherapy to the mother. Med Phys 33 (2006) 2479-2490
12. Polf J.C., and Newhauser W.D. Calculations of neutron dose equivalent exposures from range-modulated proton therapy beams. Phys Med Biol 50 (2005) 3859-3873
13. Polf J.C., Newhauser W.D., and Titt U. Patient neutron dose equivalent exposures outside of the proton therapy treatment field. Radiat Prot Dosimetry 115 (2005) 154-158
14. Roy S.C., and Sandison G.A. Scattered neutron dose equivalent to a fetus from proton therapy of the mother. Radiat Phys Chem 71 (2004) 997-998
15. Schneider U., Agosteo S., Pedroni E., and Besserer J. Secondary neutron dose during proton therapy using spot scanning. Int J Radiat Oncol Biol Phys 53 (2002) 244-251
16. Schneider U., Fiechtner A., Besserer J., and Lomax A. Neutron dose from prostheses material during radiotherapy with protons and photons. Phys Med Biol 49 (2004) N119-N124
17. Tayama R., Fujita Y., Tadokoro M., Fujimaki H., Sakae T., and Terunuma T. Measurement of neutron dose distribution for a passive scattering nozzle at the Proton Medical Research Center (PMRC). Nucl Instrum Methods Phys Res A 564 (2006) 532-536
18. Wroe A., Rosenfeld A., and Schulte R. Out-of-field dose equivalents delivered by proton therapy of prostate cancer. Med Phys 34 (2007) 3449-3456
19. Yan X., Titt U., Koehler A.M., and Newhauser W.D. Measurement of neutron dose equivalent to proton therapy patients outside of the proton radiation field. Nucl Instrum Methods Phys Res A 476 (2002) 429-434
20. Zheng Y., Newhauser W., Fontenot J., Taddei P., and Mohan R. Monte Carlo study of neutron dose equivalent during passive scattering proton therapy. Phys Med Biol 52 (2007) 4481-4496
21. Koehler A.M., Schneider R.J., and Sisterson J.M. Flattening of proton dose distributions for large-field radiotherapy. Med Phys 4 (1977) 297-301
22. Lomax A.J., Bohringer T., Bolsi A., et al. Treatment planning and verification of proton therapy using spot scanning: initial experiences. Med Phys 31 (2004) 3150-3157
23. Jones D.T.L., and Schreuder A.N. Magnetically scanned proton therapy beams: rationales and principles. Radiat Phys Chem 61 (2001) 615-618
24. Olsen D.R., Bruland O.S., Frykholm G., and Norderhaug I.N. Proton therapy - a systematic review of clinical effectiveness. Radiother Oncol 83 (2007) 123-132
25. NCRP. National council on radiation protection and measurements. The relative biological effectiveness of radiations of different quality. NCRP Report 104; 1990.
26. Rodrigues P., Trindade A., Peralta L., Alves C., Chaves A., and Lopes M.C. Application of GEANT4 radiation transport toolkit to dose calculations in anthropomorphic phantoms. Appl Radiat Isot 61 (2004) 1451-1461
27. Barquero R., Edwards T.M., Iniguez M.P., and Vega-Carrillo H.R. Monte Carlo simulation estimates of neutron doses to critical organs of a patient undergoing 18 MV X-ray LINAC-based radiotherapy. Med Phys 32 (2005) 3579-3588
28. Ferrari P, Gualdrini G, Nava E, Burn KW. Preliminary evaluations of the undesirable patient dose from a BNCT treatment at the ENEA-TAPIRO reactor. Radiat Prot Dosimetry, in press.
29. Paganetti H., Jiang H., Lee S.Y., and Kooy H.M. Accurate Monte Carlo simulations for nozzle design, commissioning and quality assurance for a proton radiation therapy facility. Med Phys 31 (2004) 2107-2118
30. Xu X.G., Chao T.C., and Bozkurt A. VIP-Man: an image-based whole-body adult male model constructed from color photographs of the Visible Human Project for multi-particle Monte Carlo calculations. Health Phys 78 (2000) 476-486
31. Egbert S.D., Kerr G.D., and Cullings H.M. DS02 fluence spectra for neutrons and gamma rays at Hiroshima and Nagasaki with fluence-to-kerma coefficients and transmission factors for sample measurements. Radiat Environ Biophys 46 (2007) 311-325
32. Nolte E., Ruhm W., Loosli H.H., et al. Measurements of fast neutrons in Hiroshima by use of Ar-39. Radiat Environ Biophys 44 (2006) 261-271
33. Kellerer A.M., Ruhm W., and Walsh L. Indications of the neutron effect contribution in the solid cancer data of the A-bomb survivors. Health Phys 90 (2006) 554-564
34. Little M.P. Estimates of neutron relative biological effectiveness derived from the Japanese atomic bomb survivors. Int J Radiat Biol 72 (1997) 715-726
35. Ullrich R.L. Tumor induction in BALB/c female mice after fission neutron or gamma irradiation. Radiat Res 93 (1983) 506-515
36. Ullrich R.L. Tumor induction in BALB/c mice after fractionated or protracted exposures to fission-spectrum neutrons. Radiat Res 97 (1984) 587-597
37. Ullrich R.L., Jernigan M.C., Cosgrove G.E., Satterfield L.C., Bowles N.D., and Storer J.B. The influence of dose and dose rate on the incidence of neoplastic disease in RFM mice after neutron irradiation. Radiat Res 68 (1976) 115-131
38. ICRU. The quality factor in radiation protection. Bethesda, MD, Report 40: International Commission on Radiation Units and Measurements.
39. ICRP. 1990 Recommendations of the International Commission on Radiological Protection: Report 60. Oxford: Pergamon Press; 1991.
40. R). Report 92 of the International Commission on Radiological Protection. Ann ICRP 2003;33:1-117.
41. NCRP. National council on radiation protection and measurements. Calibration of survey instruments used in radiation protection for the assessment of ionizing radiation fields and radioactive surface contamination. NCRP Report 112. Bethesda, MD; 1991.
42. Lloyd D.C., Purrott R.J., Dolphin G.W., and Edwards A.A. Chromosome aberrations induced in human lymphocytes by neutron irradiation. Int J Radiat Biol Relat Stud Phys Chem Med 29 (1976) 169-182
43. Sevan'kaev A.V., Zherbin E.A., Obaturov G.M., Kozlov V.M., and Tiatte E.G. Cytogenetic effects induced in vitro in human peripheral blood lymphocytes by neutrons. II. Relative biological effectiveness of neutrons having different energies. Genetika 15 (1979) 1228-1234 [in Russian]
44. Heimers A. Cytogenetic analysis in human lymphocytes after exposure to simulated cosmic radiation which reflects the inflight radiation environment. Int J Radiat Biol 75 (1999) 691-698
45. Mitaroff A., and Silari M. The CERN-EU high-energy reference field (CERF) facility for dosimetry at commercial flight altitudes and in space. Radiat Protect Dosim 102 (2002) 7-22
46. Mitelman F, Johansson B, Mertens FE. Mitelman Database of chromosome aberrations in cancer. http://cgap.nci.nih.gov/Chromosomes/Mitelman. 2007.
47. Kellerer A., and Rossi H. A generalized formulation of dual radiation action. Radiat Res 75 (1978) 471-488
48. Joiner M.C., and Field S.B. The response of mouse skin to irradiation with neutrons from the 62 MV cyclotron at Clatterbridge, U.K. Radiother Oncol 12 (1988) 153-166
49. Dale R.G., and Jones B. The assessment of RBE effects using the concept of biologically effective dose. Int J Radiat Oncol Biol Phys 43 (1999) 639-645
50. National Research Council of the National Academies. Health risks from exposure to low levels of ionizing radiation - BEIR VII. Washington, DC: The National Academies Press; 2006.
51. Land CE, Gilbert E, Smith JM. Report of the NCI-CDC working group to revise the 1985 NIH radioepidemiological tables. NIH Publication 03-5387. See also www.irep.nci.nih.gov. Bethesda: NIH; 2003. Report No.: NIH 03-5387.
52. Kry S.F., Salehpour M., Followill D.S., et al. The calculated risk of fatal secondary malignancies from intensity-modulated radiation therapy. Int J Radiat Oncol Biol Phys 62 (2005) 1195-1203
53. Hall E.J., and Wuu C.S. Radiation-induced second cancers: the impact of 3D-CRT and IMRT. Int J Radiat Oncol Biol Phys 56 (2003) 83-88
54. Phillips M.H., Pedroni E., Blattmann H., Boehringer T., Coray A., and Scheib S. Effects of respiratory motion on dose uniformity with a charged particle scanning method. Phys Med Biol 37 (1992) 223-234
55. Lambert J., Suchowerska N., McKenzie D.R., and Jackson M. Intrafractional motion during proton beam scanning. Phys Med Biol 50 (2005) 4853-4862
56. Grozinger S.O., Rietzel E., Li Q., Bert C., Haberer T., and Kraft G. Simulations to design an online motion compensation system for scanned particle beams. Phys Med Biol 51 (2006) 3517-3531
57. Timmermann B., Schuck A., Niggli F., et al. Spot-scanning proton therapy for malignant soft tissue tumors in childhood: first experiences at the Paul Scherrer Institute. Int J Radiat Oncol Biol Phys 67 (2007) 497-504
58. Weber D.C., Rutz H.P., Bolsi A., et al. Spot Scanning Proton Therapy in the Curative Treatment of Adult Patients with Sarcoma: the Paul Scherrer Institute Experience. Int J Radiat Oncol Biol Phys (2007)
59. Weber D.C., Rutz H.P., Pedroni E.S., et al. Results of spot-scanning proton radiation therapy for chordoma and chondrosarcoma of the skull base: the Paul Scherrer Institut experience. Int J Radiat Oncol Biol Phys 63 (2005) 401-409
60. Bues M., Newhauser W.D., Titt U., and Smith A.R. Therapeutic step and shoot proton beam spot-scanning with a multi-leaf collimator: a Monte Carlo study. Radiat Prot Dosimetry 115 (2005) 164-169
61. Paganetti H., and Bortfeld T. Proton therapy. In: Schlegel W., Bortfeld T., and Grosu A.-L. (Eds). New technologies in radiation oncology (2006), Springer, Berlin
62. Jones D.T.L., Schreuder A.N., de Kock E.A., et al. Proton therapy at iThemba LABS. Radiat Phys Chem 71 (2004) 983-984
63. Meier M.M., Amian W.B., Goulding C.A., Morgan G.L., and Moss C.E. Neutron yields from stopping-length targets for 256 MeV protons. Nucl Sci Eng 110 (1992) 299-301
64. Maurer R.H., Kinnison J.D., and Roth D.R. Neutron production from 200-500 MeV proton interaction with spacecraft materials. Radiat Prot Dosimetry 116 (2005) 125-130